TG Therapeutics Inc (NASDAQ: TGTX) stock closed at $40.84 on 3/14/25 after a major increase of 10.2%. Moreover, unusually high trading volume at 176% of normal accompanied the advance. The stock has risen 16.1% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
TG Therapeutics has a current Value Trend Rating of A (Highest Rating). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. TG Therapeutics has a very high Appreciation Score of 91 and a very high Power Rating of 93, leading to the Highest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment